Cesar Ibarra

ORCID: 0000-0001-9349-4254
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver Diseases and Immunity
  • Extracellular vesicles in disease
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Medical Imaging and Pathology Studies
  • MicroRNA in disease regulation
  • Parathyroid Disorders and Treatments
  • Hypertrophic osteoarthropathy and related conditions
  • Restless Legs Syndrome Research
  • Vascular anomalies and interventions
  • Genetic factors in colorectal cancer
  • Gallbladder and Bile Duct Disorders
  • Cancer Genomics and Diagnostics
  • Inflammatory Bowel Disease
  • Gastrointestinal Tumor Research and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Pediatric Hepatobiliary Diseases and Treatments

Hospital de Cruces
2017-2023

Osakidetza
2023

Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepatocellular carcinoma (HCC) is sometimes difficult. Accurate noninvasive biomarkers for PSC, CCA, HCC not available. In the search novel biomarkers, serum extracellular vesicles (EV) were isolated from (n = 43), PSC 30), or 29) patients healthy...

10.1002/hep.29291 article EN Hepatology 2017-05-27

: Cholangiocarcinoma (CCA) comprises a group of heterogeneous biliary cancers with dismal prognosis. The etiologies most CCAs are unknown, but primary sclerosing cholangitis (PSC) is risk factor. Non-invasive diagnosis CCA challenging and accurate biomarkers lacking. We aimed to characterize the transcriptomic profile serum urine extracellular vesicles (EVs) from patients CCA, PSC, ulcerative colitis (UC), healthy individuals. Serum EVs were isolated by serial ultracentrifugations...

10.3390/cells9030721 article EN cc-by Cells 2020-03-14
Coming Soon ...